Silent but potentially deadly

The sexually transmitted disease chlamydia has been strongly linked to cervical cancer in a study carried out by scientists in Finland. Chlamydia trachomatis accounted for 24,311 new infections in men and 32,544 in women in 1999. However, because most cases show no symptoms, the actual number could be 90% greater. The study, published in the Journal of the American Medical Association, found that women infected with the chlamydia strain serotype G were nearly seven times more likely to develop c


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The sexually transmitted disease chlamydia has been strongly linked to cervical cancer in a study carried out by scientists in Finland. Chlamydia trachomatis accounted for 24,311 new infections in men and 32,544 in women in 1999. However, because most cases show no symptoms, the actual number could be 90% greater. The study, published in the Journal of the American Medical Association, found that women infected with the chlamydia strain serotype G were nearly seven times more likely to develop cervical cancer (JAMA. 2001 285:47-51). Another two strains increased the risk of disease by nearly four-fold and three-fold. Also, exposure to more than one strain raised the overall risk. Dr Tarja Anttila from the National Public Health Institute and Dr Jorma Paavonen from the University of Helsinki analysed blood tests taken from 530,000 women in Finland, Norway and Sweden. One hundred and twenty-eight of the women developed invasive cervical cancer at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution